ACP-319
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ACP-319, covering 2021-09-30 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia [Phase 1]